Zoekresultaten - 6 results
La résistance antimicrobienne chez les E. coli BLSE et Commensales, Campylobacter spp., Salmonella spp., Staphylococcus aureus résistants à la méthicilline (MRSA) et Enterococcus faecalis et faecium isolés des populations d’animaux producteurs d’aliments
animale. Malgré une diminution significative de la résistance à la tétracycline (-11.2%) observée chez E. faecium isolées de porcs depuis 2019, celle-ci restait extrêmement élevée à élevée en 2020, à la fois ...
Fluoroquinolone resistance in Escherichia coli isolates after exposure to non-fluoroquinolone antibiotics: a retrospective case–control study
multiple testing there were lower odds of fluoroquinolone resistance in E. coli isolates after exposure to cefazolin (OR = 0.65; 95% CI = 0.52–0.81; P = 0.00014) and higher odds after exposure to ...
Molecular surveillance of anti-malarial drug resistance in Democratic Republic of Congo: high variability of chloroquinoresistance and lack of amodiaquinoresistance.
PCR-confirmed P. falciparum positive samples, 764 were successfully sequenced. The K76T mutation was detected in 218 samples (28.5%; 95% CI 25.4%-31.9%), mainly (96%) with the CVIET haplotype. Prevalence of CQ ...
Antimicrobial use in European acute care hospitals: results from the second point prevalence survey (PPS) of healthcare-associated infections and antimicrobial use, 2016 to 2017
CI: 29.2-31.9%). The most common indication for prescribing antimicrobials was treatment of a community-acquired infection, followed by treatment of HAI and surgical prophylaxis. Over half (54.2%) of ...
Time trend of prevalence and susceptibility to nitrofurantoin of urinary MDR Escherichia coli from outpatients
OR 1.305; 95% CI 1.220-1.397). Within the MDR isolates, the prevalence of nitrofurantoin non-susceptibility decreased from 23.2% (623/2684) in 2005 to 10.7% (455/4253) in 2011-12 (adjusted OR 0.424; ...
Point Prevalence Study of Healthcare-Associated Infections and Antimicrobial Use in Belgian Acute-Care Hospitals: Results of the ECDC PPS 2017
interval (CI): 26.8-31.1%) and 7.1% (95% CI: 6.1-8.3%), respectively. The objective of this report is to present the results of the second ECDC PPS conducted in 2017 in Belgian acute care hospitals. Methods: ...